(1)Technical University Munich, Radiation oncology, Munich, Germany;(2)Deutsches Konsortium für Translationale Krebsforschung DKTK, Partner Site Munich, Munich, Germany;(3)Helmholtz Zentrum München HMGU- - Institute of Radiation Medicine IRM, Department of Radiation Sciences DRS, Neuherberg, Germany;

¹MD Anderson Cancer Center, Radiation Oncology, Houston, USA; ²MD Anderson Cancer Center, Radiation Oncology , Houston, USA

(1)TheraPanacea, Radiotherapy, Paris, France;(2)Department of Medical Physics, Gustave Roussy - Paris-Saclay University, Villejuif, France;(3)U1030 Molecular Radiotherapy, Paris-Sud University - Gustave Roussy - Inserm - Paris-Saclay University, Villejuif, France;(4)U1018 Radiation Epidemiology, Paris-Sud University - Gustave Roussy - Inserm - Paris-Saclay University, Villejuif, France;(5)Department of Radiotherapy, Gustave Roussy - Paris-Saclay University, Villejuif, France;(6)Centre de protonthérapie d’Orsay, Institut Curie - PSL Research University, Orsay, France;(7)U1021 Normal and Pathological Signaling: from the embryo to the innovative therapy of cancers, Institut Curie - Inserm - CNRS UMR 3347 - PSL Research University - Paris-Saclay University, Orsay, France;

(1)Addenbrooke's Hospital - Oncology Centre, Medical Physics, Cambridge, United Kingdom;

¹Greater Poland Cancer Centre, Radiobiology Lab, Department of Medical Physics, Poznań, Poland; ²Greater Poland Cancer Centre, Radiobiology Lab, Department of MEdical Physics, Poznań, Poland; ³University of Medical Sciences, Department of Electroradiology, Poznań, Poland; ⁴University of Medical Sciences, Department of Electroradiology, Poznań, Poland

(1)Amsterdam University Medical Centers VUmc location, Department of Radiation Oncology, Amsterdam, The Netherlands;